What is the Latest Update on the Lipitor Diabetes Litigation?


As of mid 2015, there are more than 2,500 product liability lawsuits included in the Lipitor litigation, which all involve similar allegations that women developed type 2 diabetes following use of the cholesterol drug.

A series of federal “bellwether” trials are scheduled to begin in late 2015, with additional cases expected to go to trial throughout the first half of 2016, unless settlements are reached to resolve the litigation.

Injury Lawyers

Learn More About the Lipitor Diabetes Litigation


Millions of users of the blockbuster cholesterol drug are just now learning about the connection between Lipitor and diabetes in women, although information suggests that Pfizer knew or should have known about the risk for years.

Lipitor (atorvastatin) was first introduced in 1996 and generated more than $125 billion in sales for Pfizer before it became available as a generic in 2011.

It is one of the best known brand-name prescription medications in the world and thousands of former users may have developed type 2 diabetes as a result of the cholesterol drug.

A diabetes diagnosis from Lipitor can have a substantial impact on an individual’s overall health and quality of life, resulting in permanent lifestyle changes and increasing the risk of a number of other health problems, including the heart disease the drug was supposed to help prevent.

According to allegations raised in the Lipitor diabetes litigation, Pfizer should be required to compensate users for failing to disclose information about the potential side effects of their medication.

If proper warnings had been provided for consumers and the medical community, thousands of women may have avoided this devastating disease by choosing not to use Lipitor or by monitoring their blood glucose levels to see if the drug was adversely affecting their metabolism.

2015 Lipitor Diabetes Litigation Status

In February 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) approved a request to consolidate and centralize all Lipitor diabetes cases pending throughout the federal court system, placing the litigation before U.S. District Judge Richard M. Gergel in the District of South Carolina to reduce duplicative discovery, avoid conflicting pretrial rulings from different judges and to serve the convenience of the parties, witnesses and the courts.

While an MDL is often confused with a Lipitor class action lawsuit, each claim would still remain an individual case. The litigation will not proceed through one class representative, but each plaintiff must still establish that their specific diabetes diagnosis was caused by Lipitor and that Pfizer provided inadequate warnings.

As part of the coordinated pretrial proceedings in the Lipitor MDL, a small group of case have been prepared for early trial dates, known as “bellwether” cases, which are designed to help the parties gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation.

The first Lipitor trial is scheduled to begin in November 2015. While the outcome of this lawsuit will not be binding on other women involved in the Lipitor diabetes litigation, it may influence eventual negotiations with the drug maker to resolve large numbers of complaints.

Join the Litigation Over Lipitor

If you, a friend or family member has been diagnosed with diabetes that may have been caused by the cholesterol drug Lipitor, it is not too late to join the litigation for Lipitor. The lawyers at Saiontz & Kirk, P.A. are continuing to review potential new cases throughout the United States for women diagnosed with diabetes from Lipitor.

All cases are pursued by our law firm under a contingency fee agreement, which means that there are no Lipitor attorney fees unless a recovery is obtained. Each claim has important deadlines, known as a statute of limitations, so it is important to review any potential claim as soon as possible.


Austin Kirk
Last Updated August 10th, 2015


  1. Melanie April 18, 2016 at 2:11 pm - Reply

    I have been taking lipitor for many years. I was told it was to help my heart because of heart disease. I have recently stopped lipitor because of liver enzymes. I am going back for repeat liver function test now that I am off of lipitor. I was told approximately 5 years ago that I have diabetes. I believe it is from the lipitor.

  2. Sandra October 23, 2016 at 8:30 am - Reply

    Lipitor caused me severe ear ringing, stiff neck and loss of hearing. As soon as I stopped taking it, my hearing returned. My doctor told me the cause of my hearing loss was because I was getting old and referred me to an audiologist who said I needed hearing aids. All a money making scheme. I have developed curvature of the spine in addition and have been seeing a chiropractor to straighten out my spine and muscles. The ringing has subsided substantially. The ear ringing was equivalent to a heavy metal rock band playing in my head. The doctor told me the good outweighs the bad?? I don’t think so. Working on lowering my cholesterol levels naturally. Don’t depend on doctors to know everything. I have since switched physicians as the doctor never called me back when I asked for help. He is more interested in making the sure money at nursing homes for the unfortunate who have been kept alive by modern medicine.

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.